Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events in Patients With Cancer: an Observational and Retrospective Study Using the WHO Pharmacovigilance Database

NCT04169503 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT04169503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04169503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events in Patients With Cancer: an Observational and Retrospective Study Using the WHO Pharmacovigilance Database
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Unknown status
Start date
October 14, 2019
Completion date
February 29, 2020
Enrollment
17,562 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer